#drug development — Friday, June 12, 2026 (1 items)
| 0 | 💬 0 |
Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-06-12 | #amr #clinical trial #hiv #drug development |